title: Fear, avoidance and physiological symptoms during cognitive-behavioral therapy for social anxiety disorder.
abstract: We examined fear, avoidance and physiological symptoms during cognitive-behavioral therapy (CBT) for social anxiety disorder (SAD). Participants were 177 individuals with generalized SAD who underwent a 14-week group CBT as part of a randomized controlled treatment trial. Participants filled out self-report measures of SAD symptoms at pre-treatment, week 4 of treatment, week 8 of treatment, and week 14 of treatment (post-treatment). Cross-lagged Structural Equation Modeling indicated that during the first 8 weeks of treatment avoidance predicted subsequent fear above and beyond previous fear, but fear did not predict subsequent avoidance beyond previous avoidance. However, during the last 6 weeks of treatment both fear and avoidance predicted changes in each other. In addition, changes in physiological symptoms occurred independently of changes in fear and avoidance. Our findings suggest that changes in avoidance spark the cycle of change in treatment of SAD, but the cycle may continue to maintain itself through reciprocal relationships between avoidance and fear. In addition, physiological symptoms may change through distinct processes that are independent from those involved in changes of fear and avoidance.
authors: University of Haifa, Haifa, Israel. iaderka@psy.haifa.ac.il
authors: Idan M
authors: IM
authors: Aderka
authors: Carmen P
authors: CP
authors: McLean
authors: Jonathan D
authors: JD
authors: Huppert
authors: Jonathan R T
authors: JR
authors: Davidson
authors: Edna B
authors: EB
authors: Foa
mesh_terms: D000328:Adult; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D001362:Avoidance Learning / Q000187:drug effects; D015928:Cognitive Behavioral Therapy; D003131:Combined Modality Therapy / Q000523:psychology; D005239:Fear / Q000187:drug effects / Q000523:psychology*; D005260:Female; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D008297:Male; D063189:Symptom Assessment
chemical_list: D005473:Fluoxetine
references: J Clin Psychopharmacol. 2001 Jun;21(3):311-24
references: 11386495
references: Psychol Bull. 1990 Mar;107(2):238-46
references: 2320703
references: Behav Res Ther. 2006 Aug;44(8):1199-210
references: 16225841
references: J Consult Clin Psychol. 2005 Oct;73(5):945-952
references: 16287394
references: Behav Ther. 2016 Sep;47(5):669-674
references: 27816079
references: J Behav Ther Exp Psychiatry. 2008 Jun;39(2):147-61
references: 17433252
references: Behav Res Ther. 2010 Mar;48(3):226-37
references: 19954772
references: J Consult Clin Psychol. 2004 Jun;72(3):392-399
references: 15279523
references: Depress Anxiety. 2003;18(1):29-40
references: 12900950
references: J Consult Clin Psychol. 2009 Apr;77(2):317-27
references: 19309190
references: Psychometrika. 2010 Jun;75(2):243-248
references: 20640194
references: Clin Psychol Rev. 2004 Nov;24(7):883-908
references: 15501560
references: Arch Gen Psychiatry. 2004 Oct;61(10):1005-13
references: 15466674
references: J Anxiety Disord. 2009 May;23(4):496-503
references: 19081225
references: J Anxiety Disord. 2005;19(1):69-86
references: 15488368
references: Behav Res Ther. 1997 Aug;35(8):741-56
references: 9256517
references: Psychol Med. 2009 Feb;39(2):241-54
references: 18507874
references: Aust N Z J Psychiatry. 1999 Aug;33(4):503-10
references: 10483844
references: Behav Res Ther. 1999 Nov;37(11):1119-28
references: 10500324
references: Psychol Med. 1997 Jan;27(1):161-6
references: 9122296
references: J Abnorm Psychol. 2004 May;113(2):189-97
references: 15122939
references: J Abnorm Psychol. 1997 Aug;106(3):416-24
references: 9241943
references: Behav Res Methods Instrum Comput. 2004 Nov;36(4):717-31
references: 15641418
references: J Consult Clin Psychol. 2006 Jun;74(3):568-78
references: 16822113
references: J Consult Clin Psychol. 1997 Aug;65(4):694-8
references: 9256571
references: Behav Res Ther. 1997 Dec;35(12):1113-21
references: 9465444
references: Depress Anxiety. 2006;23(1):6-10
references: 16216019
references: J Psychopharmacol. 2007 Jan;21(1):102-11
references: 16714326
references: J Clin Psychiatry. 1991 Nov;52 Suppl:48-51
references: 1757457
references: J Abnorm Psychol. 2001 May;110(2):247-58
references: 11358019
references: Arch Gen Psychiatry. 2005 Jun;62(6):593-602
references: 15939837
references: J Clin Psychiatry. 1994 Jun;55 Suppl:28-32
references: 8077166
references: Depress Anxiety. 2010 Feb;27(2):168-89
references: 20143427
references: Biol Psychol. 2009 May;81(2):86-94
references: 19428972
references: Cogn Behav Ther. 2007;36(4):193-209
references: 18049945
references: J Anxiety Disord. 2010 Jun;24(5):528-34
references: 20399602
references: Psychol Bull. 1989 Sep;106(2):315-7
references: 2678203
references: J Consult Clin Psychol. 2003 Dec;71(6):1058-67
references: 14622081
references: Psychol Methods. 2011 Jun;16(2):93-115
references: 21500915